Correlation Between Candel Therapeutics and Vir Biotechnology
Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and Vir Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and Vir Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Candel Therapeutics and Vir Biotechnology, you can compare the effects of market volatilities on Candel Therapeutics and Vir Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of Vir Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and Vir Biotechnology.
Diversification Opportunities for Candel Therapeutics and Vir Biotechnology
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Candel and Vir is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and Vir Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vir Biotechnology and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with Vir Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vir Biotechnology has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and Vir Biotechnology go up and down completely randomly.
Pair Corralation between Candel Therapeutics and Vir Biotechnology
Given the investment horizon of 90 days Candel Therapeutics is expected to generate 2.01 times more return on investment than Vir Biotechnology. However, Candel Therapeutics is 2.01 times more volatile than Vir Biotechnology. It trades about 0.06 of its potential returns per unit of risk. Vir Biotechnology is currently generating about 0.02 per unit of risk. If you would invest 657.00 in Candel Therapeutics on September 12, 2024 and sell it today you would earn a total of 118.00 from holding Candel Therapeutics or generate 17.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Candel Therapeutics vs. Vir Biotechnology
Performance |
| Timeline |
| Candel Therapeutics |
| Vir Biotechnology |
Candel Therapeutics and Vir Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Candel Therapeutics and Vir Biotechnology
The main advantage of trading using opposite Candel Therapeutics and Vir Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, Vir Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vir Biotechnology will offset losses from the drop in Vir Biotechnology's long position.| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
| Vir Biotechnology vs. CureVac NV | Vir Biotechnology vs. Krystal Biotech | Vir Biotechnology vs. Propanc Biopharma | Vir Biotechnology vs. Blueprint Medicines Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |